Why is Aarti Pharma falling/rising?

As of 19-Sep, Aarti Pharmalabs Ltd's stock price is currently at Rs 926.00, reflecting an increase of Rs 24.25 or 2.69%. The stock has shown a strong performance today, outperforming its sector by 2.42% and reaching an intraday high of Rs 939.95, which is 4.24% higher than its previous close. Over the past month, the stock has gained 9.59%, and year-to-date, it has risen by 34.74%. Despite this positive momentum, there has been a notable decline in investor participation, with delivery volume falling by 29.9% against the 5-day average. The company's strong fundamentals, including a low Debt to EBITDA ratio of 0.63 and a return on capital employed (ROCE) of 16.1, contribute to its attractive valuation, which is currently trading at a discount compared to peers.
In the broader market context, the stock's performance over the past year has significantly outpaced the benchmark, with Aarti Pharmalabs generating a return of 39.91% compared to the BSE500's negative return of -1.96%. While the stock has been performing well in the longer term, it is currently 4.91% away from its 52-week high, indicating potential for further growth. The overall market has shown a slight positive return of 0.88% over the past week, while Aarti Pharmalabs has remained relatively flat during that period. This combination of strong individual performance and a favorable market environment suggests that the stock's recent rise is supported by both its solid fundamentals and broader market trends.